reported side effects of metformin/sitagliptin
lactic acidosis
other side effects
nausea
comprehensive list of adverse effects
metformin-sitagliptin
hypoglycemia
sulfonylurea
insulin
hypoglycemia
decrease levels of vitamin b without clinical manifestations
anemiarare
lactic acidosis
metforminsitagliptin
hypoglycemiametformin
hypoglycemia
glyburide
hypoglycemiavery
lactic acidosis
vitamin b deficiency
metformin-treated patients
incidence of lactic acidosis
cases
patient years
risk of lactic acidosis
patients
underlying
underlying renal insufficiency
patients with normal renal function
liver disease
sepsis
hypoxia
risk of lactic acidosis
signs
symptoms of severe acidosis
vomiting
abdominal pain
nausea
dyspnea
hypothermia
hypotension
bradycardia
long-term treatment with metformin
decrease in vitamin b absorption
malabsorption of vitamin b
intrinsic factor deficiency
other mechanisms
treated patients
megaloblastic anemia
decreased levels of vitamin b
discontinuation of metformin
vitamin b supplementation
diarrhea
nausea
flatulence
vomiting
constipation
upper abdominal pain
dry mouthpostmarketing reports
indigestion
abdominal discomfort
dyspepsia
abdominal pain
acute pancreatitis
including
necrotizing pancreatitis
metformin
nausea
vomiting
diarrhea
abdominal pain
loss of appetite sitagliptin
pancreatitis
metformin-sitagliptin
headacheuncommon
somnolencefrequency
astheniametformin
metallic taste
upper
respiratory tract infections
nasopharyngitis
pharyngolaryngeal pain
bronchitis
sinusitis
influenzapostmarketing reports
interstitial lung disease
frequency
hypersensitivity reactions
anaphylaxis
metformin-sitagliptin
postmarketing reports
hepatic enzyme elevationmetformin
liver function disorders
hepatitis
frequency
impaired renal function
acute renal failure
requiring dialysis
october
december
cases of severe arthralgia
fda
adverse event reporting system database
case
use
more dipeptidyl peptidase
inhibitor
cases
substantial reduction in prior activity level
patients
disabling
disabling joint pain
cases
symptoms
month
starting therapy
cases symptoms
month after discontinuation
positive rechallenge
cases
cases
involving use of a different dpp
inhibitor
sitagliptin
greatest number of cases
n =-rrb-
saxagliptin
n =-rrb-
linagliptin
n =-rrb-
alogliptin
n =-rrb-
vildagliptin
n =-rrb-
arthralgiapostmarketing reports
myalgia
pain in extremities
pain
peripheral edema
postmarketing reports
angioedema
rash
urticaria
pruritus
cutaneous vasculitis
exfoliative skin conditions
steven-johnson syndromemetformin
urticaria
erythema
pruritus
megaloblastic anemia
decreased serum vitamin b levels
clinical manifestations
megaloblastic anemia
patients
reduction in vitamin b levels
interference with b absorption from the b-intrinsic factor complex
discontinuation of metformin
vitamin b supplementation
anxiety
blurred vision
chills
cold sweats
confusion
cool, pale skin
depression
dizziness
fast heartbeat
headache
increased hunger
loss of consciousness
mental cloudiness
nausea
nightmares
not thinking clearly
seizures
shakiness
slurred speech
unusual tiredness
weakness
stomach discomfort
decreased appetite
diarrhea
fast, shallow breathing
general feeling of discomfort
muscle pain
cramping
shortness of breath
sleepiness
blistering
peeling
loosening of the skin
darkened urine
hives
welts
itching
skin rash
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
loss of appetite
pains in the stomach
side
abdomen
radiating
back
puffiness
swelling of the eyelids
eyes
face
lips
tongue
red skin lesions
purple center
severe joint pain
sores
ulcers
white spots in the mouth
lips
vomiting
yellow eyes
skin
full feeling
excess air
gas in the stomach
intestines
indigestion
lack
loss of strength
muscle aches
passing gas
sore throat
runny nose
vomiting